Keyword: samsung bioepis


Biogen/Samsung Bioepis End Patent Dispute with AbbVie

10.04.2018 - Biogen and partner Samsung Bioepis have reached agreement with AbbVie regarding the commercialization of Imraldi, their biosimilar form of the latter’s blockbuster Humira. Specific...


Samsung Bioepis and Takeda in Biologics Pact

23.08.2017 - South Korean biopharmaceutical company Samsung Bioepis is taking its first step into novel drug development with an agreement to partner Japan’s Takeda Pharmaceutical. The move...